Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alkylglycerol monooxygenase (AGMO; EC 18.104.22.168) cleaves the O-alkyl bonds of ether lipids, which are essential components of brain membranes and function in cell signaling and other critical biologic processes. Zusätzlich bieten wir Ihnen und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 13 products:
We identified homozygous and heterozygous mutations of the alkylglycerol monooxygenase (AGMO) gene (MIM (zeige MTSS1 Antikörper) 613738) as the likely cause of visceral leishmaniasis relapse in 3 families.
An AGMO mutation was found in a Saudi family underlying primary microcephaly and intellectual disability.
Transmembrane protein 195 has tetrahydrobiopterin-dependent alkylglycerol monooxygenase activity (also known as glyceryl-ether monooxygenase activity, E.C. 22.214.171.124).
These results demonstrate a central role of tetrahydrobiopterin and alkylglycerol monooxygenase in ether lipid metabolism of murine macrophages.
Results suggest a possible mechanism for Alkylglycerol monooxygenase (AGMO) in modulating macrophage platelet-activating factor (PAF (zeige KIAA0101 Antikörper)) production by regulating cellular lyso-PAF (zeige KIAA0101 Antikörper) levels.
The protein encoded by this gene is a tetrahydrobiopterin- and iron-dependent enzyme that cleaves the ether bond of alkylglycerols. Sequence comparisons distinguish this protein as forming a third, distinct class of tetrahydrobiopterin-dependent enzymes. Variations in this gene have been associated with decreased glucose-stimulated insulin response, type 2 diabetes, and susceptibility to intracranial aneurysms.
, transmembrane protein 195